YMI marketing campaign update – November 16, 2022


YMI marketing campaign update.

Calgary, Alberta – November 16, 2022

For Immediate Release – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT)(OTCQB:NDATF) is pleased to announce that the Corporation’s marketing contractor, BelieveCo (formerly VenturePlay), has provided an interim update of the YMI marketing campaign (the “Campaign”) progress. BelieveCo reports that after only one month, “The media campaign has been performing incredibly” and “the data shows that we’re performing well over benchmarks”.

NDAT’s President Jim Durward states: “We planned our work and we’re working our plan. I’m very pleased that Phase 1 of the marketing strategy has performed so well. As expected, prospective customers were driven to the YMI website and their “in-site” behaviour tracked to provide valuable knowledge into pre-purchase behaviors during the purchase process. We will now incorporate this knowledge in Phase 2 and increase the resolution of our behavioral data gathering to optimize the overall purchase process.”


In the near term the Corporation expects to expand the Campaign by:

a) contracting social media influencers – relevant influencers have been identified and outreach has begun;

b) incorporating social media “boosts” – expected to begin before November 30, 2022;

c) increasing the digital advertising spend – expected before the end of November, 2022; and

d) expanding the target geography to include all of Canada – expected before December 15, 2022.


The Corporation further reports that an introductory price reduction occurred during Phase 1 and that the small number of sales that occurred prior to the price reduction were refunded as a show of goodwill to those customers – meaning the pre-reduction customers were effectively given free access to YMI. The refunds will not have a material effect on the Corporation’s financial statements. The Campaign is fully funded by the Corporation’s existing cash balance.

YMI is available now at https://ymihealth.ca/


About nDatalyze Corp.:

nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application with it’s database licensing division focusing on providing a specialized health-related Reference Database to application developers and researchers. YMI is based on the Corporation’s proprietary Reference Database consisting of >1200 biometric records complete with associated electroencephalogram (“EEG”) data. With installations worldwide, it’s Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development and accordingly the Corporation cannot accurately predict if or when this application will become a cash flow generator.



nDatalyze Corp.
James Durward, President and CEO
Telephone: (403) 689-3901
Email: [email protected]

Website: www.ndatalyze.com


Investor Relations
RBMG – RB Milestone Group LLC
[email protected]

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.